Cargando…

Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancer

BACKGROUND: There is no information in the literature on the impact of changes in quality of life (QoL) scores on prognosis in ovarian cancer. We investigated whether changes in QoL during treatment could predict survival in ovarian cancer patients. METHODS: We evaluated 137 ovarian cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Digant, Braun, Donald P, Staren, Edgar D, Markman, Maurie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601016/ https://www.ncbi.nlm.nih.gov/pubmed/23510606 http://dx.doi.org/10.1186/1757-2215-6-17

Ejemplares similares

Predicting survival in prostate cancer: the role of quality of life assessment
por: Braun, Donald P., et al.
Publicado: (2011)

Quality of life assessment as a predictor of survival in non-small cell lung cancer
por: Braun, Donald P, et al.
Publicado: (2011)

Prognostic value of changes in quality of life scores in prostate cancer
por: Gupta, Digant, et al.
Publicado: (2013)

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?
por: Braun, Donald P, et al.
Publicado: (2011)

The relationship between patient satisfaction with service quality and survival in pancreatic cancer
por: Gupta, Digant, et al.
Publicado: (2012)

Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literature
por: Lis, Christopher G, et al.
Publicado: (2012)

Can Quality of Life Assessments Differentiate Heterogeneous Cancer Patients?
por: McCabe, Ryan M., et al.
Publicado: (2014)

Update on the utility of prognostic biomarkers in ovarian cancer
por: Markman, Maurie
Publicado: (2009)

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
por: Markman, Maurie
Publicado: (2009)

New developments in the anti-neoplastic drug management of ovarian cancer
por: Markman, Maurie
Publicado: (2013)

Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
por: Markman, Maurie
Publicado: (2018)

Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancer
por: Markman, Maurie
Publicado: (2010)

Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
por: Markman, Maurie
Publicado: (2011)

Involvement of Bone in Epithelial Ovarian Cancer: Case Report of an Uncommon Late Metastatic Event
por: Markman, Maurie
Publicado: (2011)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: Where Do We Go From Here?
por: Markman, Maurie
Publicado: (2016)

Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
por: Gupta, Digant, et al.
Publicado: (2010)

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
por: Anand, Rachna, et al.
Publicado: (2011)

Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
por: Chen, Jian, et al.
Publicado: (2009)

A Case Report Demonstrating Unambiguous Clinical Utility of Pet/CT Scanning in Recurrent Ovarian Cancer
por: Mutch, David, et al.
Publicado: (2009)

An Example of Ovarian Cancer as a ‘Chronic Disease Process' – 11-Year Survival with Multiple Treatments for Recurrent and Progressive Disease
por: Markman, Maurie, et al.
Publicado: (2008)

Case of Ovarian Cancer in a Woman with Undiagnosed Graves’ Disease: A Case Report and Review of the Literature
por: Markman, Timothy M., et al.
Publicado: (2017)

Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients
por: Niu, Jiaxin, et al.
Publicado: (2015)

Patient satisfaction with service quality in an oncology setting: implications for prognosis in non-small cell lung cancer
por: Gupta, Digant, et al.
Publicado: (2013)

Withholding Recognized Effective Adjuvant Anti-Neoplastic Chemotherapy in a Setting with Known Highly Active Treatment for Recurrent Disease: A Case Report
por: Markman, Maurie
Publicado: (2010)

Is It Time to Inform This Patient that Further Antineoplastic Drug Therapy Will Not Be of Clinical Value?
por: Markman, Maurie
Publicado: (2010)

Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018)

Cardio-oncology: management of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2019)

Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life
por: Lis, Christopher G, et al.
Publicado: (2009)

Comprehensive genomic profiling (CGP) of ovarian clear cell carcinomas (OCCC) identifies clinically relevant genomic alterations (CRGA) and targeted therapy options
por: Elvin, Julia A., et al.
Publicado: (2017)

A Case Report of Hodgkin's Lymphoma in a Patient with Carcinosarcoma of the Bladder
por: Perre, Anthony, et al.
Publicado: (2011)

Early Onset of Platinum Hypersensitivity in a Dentist: A Case Report
por: Markman, Maurie, et al.
Publicado: (2010)

Hypersensitivity following Retreatment with Carboplatin a Decade after Completion of Primary Platinum-Based Chemotherapy
por: Williams, Laura, et al.
Publicado: (2009)

Management of Two Cases of Recurrent Anal Carcinoma
por: Klimant, Eiko, et al.
Publicado: (2013)

A longitudinal study investigating quality of life and nutritional outcomes in advanced cancer patients receiving home parenteral nutrition
por: Vashi, Pankaj G, et al.
Publicado: (2014)

Cyclophosphamide-Induced Severe Acute Hyponatremic Encephalopathy in Patients with Breast Cancer: Report of Two Cases
por: Baker, Michelle, et al.
Publicado: (2014)

Pegylated Liposomal Doxorubicin-Induced Acute Transient Encephalopathy in a Patient with Breast Cancer: A Case Report
por: Baker, Michelle, et al.
Publicado: (2014)

A Case Report Demonstrating the Potential Clinical Relevance of Liquid Tumor Biopsies in Lung Cancer
por: Suppiah, Revathi, et al.
Publicado: (2016)

Utilization of Behavioral Medicine Services to Refine Medical Diagnostic Formulation in the Face of Uncertain Symptom Presentation
por: Moore, David A., et al.
Publicado: (2016)

Synchronous Presentation of a Primary Iliac Lymph Node Plasmacytoma and a Prostate Adenocarcinoma
por: Klimant, Eiko, et al.
Publicado: (2011)

Clinically Meaningful Responses to Sequential Gemcitabine-Based Chemotherapy Regimens in a Patient with Metastatic Pancreatic Cancer
por: Klimant, Eiko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_odl5s2l6rlo34lfjkjptj8tj4a